Stock Yearly Return 2013
Start date: 12/31/2012
End date: 12/31/2013
Start price/share: $149.16
End price/share: $175.20
Dividends collected/share: $0.00
Total return: 17.46%
Average Annual Total Return: 17.46%
Starting investment: $10,000.00
Ending investment: $11,746.00
Years: 1.00


ACOR average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare ACOR average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into ACOR


Also see:
ACOR stock yearly return 2014
ACOR stock yearly return 2015
ACOR stock yearly return 2016
ACOR stock yearly return 2017
ACOR stock yearly return 2018
ACOR stock yearly return 2019
ACOR stock yearly return 2020
ACOR YTD return
ACOR average annual return 10 years
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija is for as needed use and utilizes Co.'s ARCUS pulmonary delivery system. Co. also markets branded Ampyra (dalfampridine), extended release tablets, 10 mg for improving walking in people with multiple sclerosis. Co.'s ARCUS development has been focused on a program for acute treatment of migraine. The ACOR stock yearly return is shown above.

The yearly return on the ACOR stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2013 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the ACOR annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACOR:
ACOR SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ACRS Average Annual Return
ACRX Average Annual Return
ACST Average Annual Return
ADMA Average Annual Return
ADMP Average Annual Return
ADMS Average Annual Return
ADPT Average Annual Return
ADRO Average Annual Return
ADUS Average Annual Return
ADVM Average Annual Return
More Healthcare companies »

 

ACOR Stock Yearly Return 2013 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.